Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Rheumatoid Arthritis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Rheumatoid Arthritis
    Anti-TNF Treatment Does Not Increase Cancer Risk in Patients With RA - (DGNews)
    TopAbstracts in Rheumatoid Arthritis 10/29/2009 - (DGNews)
    Tocilizumab Plus Methotrexate Provides Sustained Benefits in Patients With RA: Presented at ACR/ARHP - (DGDispatch)
    Novel JAK Inhibitor Shows Promise as an Effective Treatment for Rheumatoid Arthritis: Presented at ACR/ARHP - (DGDispatch)
    Oral Syk Kinase Inhibitor Improves Response Rates in RA Patients on Methotrexate: Presented at ACR/ARHP - (DGDispatch)

    News archive

     Recent webcasts/CME - Rheumatoid Arthritis
      Comorbidity in Patients with Rheumatoid Arthritis: What are the Real Concerns?
      Advances in Basic Science
      Quantitatively-Driven Management of Rheumatoid Arthritis
      Cancer, Liver, Infections, Cardiovascular Disease, and other Biologic Agents
      Rheumatoid Arthritis: Clinical Aspects, Outcomes, and Measures

      Webcasts/CME archive

       Recent cases - Rheumatoid Arthritis
        Mesenteric Rheumatoid Nodules Masquerading as an Intra-Abdominal Malignancy: A Case Report and Review of the Literature
        Co-Existence of Acute Myeloid Leukemia with Multilineage Dysplasia and Epstein-Barr Virus-Associated T-Cell Lymphoproliferative Disorder in a Patient with Rheumatoid Arthritis
        Patient with Hepatitis B and Rheumatoid Arthritis
        Complete Heart Block and Severe Aortic Stenosis in a Patient with Rheumatoid Arthtritis: A Case Report
        Limited Wegener's Granulomatosis Presenting as Lung Nodules in a Patient with Rheumatoid Arthritis: A Case Report

        Cases archive
          




        my personal edition > rheumatoid arthritis > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        A Clue To Rheumatoid Arthritis In Osteoprotegerin Expression?

        A DGReview of :"Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls."
        Rheumatology

        01/09/2003
        By Anne MacLennan


        A deficiency in osteoprotegerin (OPG) expression in the inflamed joint of rheumatoid arthritis patients with synovitis may be important in the development of radiologically defined joint erosions.

        This is the suggestion of an analysis of synovial tissue OPG expression in patients with rheumatoid arthritis (RA), spondyloarthropathies and osteoarthritis and in normal control subjects.

        In contrast to spondyloarthropathy patients with active synovitis, patients with RA and active synovitis have deficient OPG expression on both macrophage type synovial lining cells and endothelial cells, reports this multicentre study from Australia and the Netherlands.

        Led by Dr D R Haynes from the University of Adelaide, Adelaide, the investigators sought to demonstrate, in RA patients, the expression of OPG and receptor activator of nuclear factor kappaB ligand (RANKL) in synovial tissue. They also wanted to establish the cell lineage expressing OPG and compare the OPG expression in RA, spondyloarthropathies, osteoarthritis and normal synovial tissue.

        Synovial biopsy specimens were obtained by arthroscopy from 16 RA and 12 spondyloarthropathy patients with active synovitis of a knee joint, six RA patients with no evidence of active synovitis, 10 patients with osteoarthritis and 18 normal subjects.

        Immunohistological analysis was done using monoclonal antibodies (mAb) to detect OPG and RANKL expression, and dual immunohistochemical evaluation was done with lineage-specific monoclonal antibodies (macrophages, fibroblasts and endothelial cells) and OPG. This was to determine the cell lineages expressing OPG.

        Sections were evaluated by computer-assisted image analysis and semiquantitative analysis.

        Two patterns of OPG expression emerged, one exclusively in endothelial cells and one expressed predominantly in macrophages in the synovial lining layer. Both patterns of OPG staining could be blocked with excess recombinant OPG.

        In all synovial tissues except those from patients with active RA, there was endothelial and synovial lining OPG expression.

        In contrast to this, RANKL expression was seen predominantly in synovial tissue from patients with active disease, mainly in sublining regions, particularly within areas of lymphocyte infiltration.
        Rheumatology (Oxford) 2003 Jan;42(1):123-134. "Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls."

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send